2[1]Hansen O, Johansson BW, Gullberg B. Circadian distribution of onset of acute myocardial infarction in subgroups from analysis of 10,791 patients treated in a single center. Am J Cardiol, 1992,69:1003-1008.
4[3]Willich SN, Levy D, Rocco MB, et al. Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. Am J Cardiol, 1987,60: 801--806.
5[4]Thakur RK, Hoffmann RG, Olson DW, et al. Circadian variation in sudden cardiac death: effects of age, sex, and initial cardiac rhythm.Ann Emerg Med, 1996, 27:29--34.
6[5]Willich SN. Circadian variation and triggering of cardiovascular events.Vasc Med, 1999,4:41-49.
7[6]Mulcahy D, Keegan J, Cunningham D, et al. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet,1988,2: 755--759.
8[7]Li JJ, Huang CX, Fang CH, et al. Circadian variation in ischemic threshold in patients with stable angina: relation to plasma endothelin-1.Angiology, 2002,53:409--413.
9[8]Parker JD, Testa MA, Jimenez AH, et al. Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand. Circulation, 1994,89:604-614.
10[9]Bremner WF, Sothem RB, Kanabrocki EL, et al. Relation between circadian patterns in levels of circulating lipoprotein (a), fibrinogen,platelets, and related lipid variables in men. Am Heart J, 2000, 139:164-173.
5ANTONIUCCI D, RODRIGUEZ A, HEMPEL A, et al. A randomized trial comparing primary infarct ar- tery stenting with or without abciximab in acute myo- cardial infaretion[J]. J Am Coll Cardiol, 2003, 42: 1879-1885.
6WOHRLE J,GREBE O C,NUSSER T,et al. Reduc- tion of major adverse cardiac events with intraeoro- nary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty [J]. Circulation, 2003,107 : 1840-1843.
7WU T G,ZHAO Q,HUANG W G,et al. Effect of in traeoronary tirofiban in patients undergoing percuta neous coronary intervention for acute coronary syn drome[J]. Cire J, 2008,72 : 1605 - 1609.
8STONE G W,GRINES C L,COX D A,et al. For the CADILLAC Investigators. Comparison of angioplasty with stenting, with or without ahciximab, in acute my- ocardial infarction[J]. N Engl J Med, 2002,346:957 -966.
9I.EE D P,HERITY N A,HIAT B L,et al. Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angio- graphic outcomes: Results of the Tirofiban Given in the Emergency Room before Primary Angiopiasty (TIGER-PA) Pilot Trial [J ]. Circulation, 2003, 107 : 1497-1501.
10VALGIMIGLI M, CAMPO G, PERCOCO G, et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus elu- ting or uncoated stents for acute myocardial infarc- tion:The MULTISTRATEGY Randomized Trial[J]. JAMA, 2008,299 : 1788- 1799.
